2021
DOI: 10.1073/pnas.2026491118
|View full text |Cite
|
Sign up to set email alerts
|

Scaffolding mechanism of arrestin-2 in the cRaf/MEK1/ERK signaling cascade

Abstract: Arrestins were initially identified for their role in homologous desensitization and internalization of G protein–coupled receptors. Receptor-bound arrestins also initiate signaling by interacting with other signaling proteins. Arrestins scaffold MAPK signaling cascades, MAPK kinase kinase (MAP3K), MAPK kinase (MAP2K), and MAPK. In particular, arrestins facilitate ERK1/2 activation by scaffolding ERK1/2 (MAPK), MEK1 (MAP2K), and Raf (MAPK3). However, the structural mechanism underlying this scaffolding remains… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
36
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 38 publications
(39 citation statements)
references
References 61 publications
1
36
1
Order By: Relevance
“…Whether β-arrestin 1 needs to be activated by a phosphorylated receptor for cRaf binding remains controversial. Our results, with HDX-MS and in cell BRET assays, suggest that activated receptors are not required for β-arrestin 1 and cRaf interaction, while a recent study using a GST pull-down assay showed an increased β-arrestin 1 and cRaf interaction when V2Rpp, a phosphorylated C-terminal peptide of the V2 vasopressin receptor, was co-incubated [44,55]. Therefore, further studies are needed to fully understand whether receptor-mediated β-arrestin 1 activation is required for cRaf binding.…”
Section: Structural Mechanism Of Scaffolding Erk1/2 Signaling By β-Ar...contrasting
confidence: 48%
See 3 more Smart Citations
“…Whether β-arrestin 1 needs to be activated by a phosphorylated receptor for cRaf binding remains controversial. Our results, with HDX-MS and in cell BRET assays, suggest that activated receptors are not required for β-arrestin 1 and cRaf interaction, while a recent study using a GST pull-down assay showed an increased β-arrestin 1 and cRaf interaction when V2Rpp, a phosphorylated C-terminal peptide of the V2 vasopressin receptor, was co-incubated [44,55]. Therefore, further studies are needed to fully understand whether receptor-mediated β-arrestin 1 activation is required for cRaf binding.…”
Section: Structural Mechanism Of Scaffolding Erk1/2 Signaling By β-Ar...contrasting
confidence: 48%
“…cRaf is composed of a Ras-binding domain (RBD), C1 domain (CRD), hinge region, and kinase domain (Figure 2C, left) [53,54], and K84 is located within the RBD. A recent hydrogen/deuterium exchange mass spectrometry (HDX-MS) study with purified β-arrestin 1 and cRaf RBD confirmed that the back loop of β-arrestin 1 (i.e., near R307) interacts with cRaf RBD (Figure 2D) [44]. It is interesting to note that the kinase activity of the Raf family is auto-inhibited by the N-terminal domains, including RBD and CRD, and the binding of Ras to RBD releases the N-terminal domain, leading to exposure of the kinase domain (Figure 2C, right) [53].…”
Section: Structural Mechanism Of Scaffolding Erk1/2 Signaling By β-Ar...mentioning
confidence: 77%
See 2 more Smart Citations
“…In addition, many receptors recruit a member of the key GPCR scaffolding protein family, the arrestins/b-arrestins (the non-visual arrestins comprised of b-arrestin 1 and barrestin 2) following receptor activation and phosphorylation. The b-arrestins play numerous roles in regulating GPCR activity in part due to its ability to adopt multiple distinct conformations in complex with the receptor (7)(8)(9)(10)(11), although its ability to associate with other signal proteins, including G proteins, have also been reported (12)(13)(14)(15)(16)(17). Thus, in addition to classical roles in G protein-uncoupling and receptor internalization, b-arrestins can form signalosomes that interact with multiple partners and induce diverse downstream signaling pathways.…”
Section: Introductionmentioning
confidence: 99%